Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
47
pubmed:dateCreated
2006-11-23
pubmed:abstractText
Spinal and bulbar muscular atrophy (SBMA) is a hereditary neurodegenerative disease caused by an expansion of a trinucleotide CAG repeat encoding the polyglutamine tract in the androgen receptor (AR) gene. To elucidate the pathogenesis of polyglutamine-mediated motor neuron dysfunction, we investigated histopathological and biological alterations in a transgenic mouse model of SBMA carrying human pathogenic AR. In affected mice, neurofilaments and synaptophysin accumulated at the distal motor axon. A similar intramuscular accumulation of neurofilament was detected in the skeletal muscle of SBMA patients. Fluoro-gold labeling and sciatic nerve ligation demonstrated an impaired retrograde axonal transport in the transgenic mice. The mRNA level of dynactin 1, an axon motor for retrograde transport, was significantly reduced in the SBMA mice resulting from pathogenic AR-induced transcriptional dysregulation. These pathological events were observed before the onset of neurological symptoms, but were reversed by castration, which prevents nuclear accumulation of pathogenic AR. Overexpression of dynactin 1 mitigated neuronal toxicity of the pathogenic AR in a cell culture model of SBMA. These observations indicate that polyglutamine-dependent transcriptional dysregulation of dynactin 1 plays a crucial role in the reversible neuronal dysfunction in the early stage of SBMA.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
22
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
12106-17
pubmed:meshHeading
pubmed-meshheading:17122035-Analysis of Variance, pubmed-meshheading:17122035-Animals, pubmed-meshheading:17122035-Axonal Transport, pubmed-meshheading:17122035-Blotting, Western, pubmed-meshheading:17122035-Bungarotoxins, pubmed-meshheading:17122035-Castration, pubmed-meshheading:17122035-Disease Models, Animal, pubmed-meshheading:17122035-Humans, pubmed-meshheading:17122035-Immunohistochemistry, pubmed-meshheading:17122035-In Situ Hybridization, pubmed-meshheading:17122035-Mice, pubmed-meshheading:17122035-Mice, Inbred C57BL, pubmed-meshheading:17122035-Mice, Transgenic, pubmed-meshheading:17122035-Microtubule-Associated Proteins, pubmed-meshheading:17122035-Motor Neuron Disease, pubmed-meshheading:17122035-Muscle, Skeletal, pubmed-meshheading:17122035-Neuroblastoma, pubmed-meshheading:17122035-Neurofilament Proteins, pubmed-meshheading:17122035-Peptides, pubmed-meshheading:17122035-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:17122035-Sciatic Neuropathy, pubmed-meshheading:17122035-Spinal Cord, pubmed-meshheading:17122035-Stilbamidines, pubmed-meshheading:17122035-Synaptophysin, pubmed-meshheading:17122035-Time Factors
pubmed:year
2006
pubmed:articleTitle
Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration.
pubmed:affiliation
Department of Neurology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550, Japan.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't